Quinoxaline and quinoline derivatives as kinase inhibitors
US8399483B2 · kind B2 · utility
51Cited by
0References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2008 |
| Grant date | Mar 19, 2013 |
| Priority date | — |
| Expiry date | Mar 27, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/36
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
A series of heteroaryl-substituted quinoxaline and quinoline derivatives, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions, said substituted derivatives having the general formula
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.